Literature DB >> 12576173

The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice.

Hae Sook Noh1, Yoon Sook Kim, Hee Po Lee, Ki Myung Chung, Dong Wook Kim, Sang Soo Kang, Gyeong Jae Cho, Wan Sung Choi.   

Abstract

This study was designed to evaluate the antiapoptotic effects of a ketogenic diet (KD) through histological (cresyl violet staining, TUNEL staining and immunohistochemistry) and behavioral studies using kainic acid (KA, 25mg/kg i.p.)-induced seizures in male ICR mice. KA-induced seizure in rodents is widely used as an experimental model for human temporal lobe epilepsy because of their behavioral and pathological similarities. A KA-induced seizure causes neuronal damage in hippocampal pyramidal neurons and involves a caspase-3-mediated apoptotic pathway. In this study, the seizure onset time of the KD-fed group was delayed compared to that of the group fed a normal diet (ND) after a systemic KA injection. Histological studies revealed that KA caused pyknosis in most of the hippocampal areas in the ND-fed group, however, well-preserved pyramidal neurons were detected in the hippocampus of mice that had been on KD for 1 month, which began on postnatal day 21. The number of TUNEL-positive cells and caspase-3-positive cells in the hippocampus of the KD-fed group was lower than that of the ND-fed group. These findings indicate that KD has an antiepileptic effect via a neuroprotective action that involves the inhibition of caspase-3-mediated apoptosis of hippocampal neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576173     DOI: 10.1016/s0920-1211(02)00262-0

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  31 in total

1.  D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo.

Authors:  Jana Mejía-Toiber; Teresa Montiel; Lourdes Massieu
Journal:  Neurochem Res       Date:  2006-11-18       Impact factor: 3.996

2.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

Review 3.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

Review 4.  Cerebral metabolic adaptation and ketone metabolism after brain injury.

Authors:  Mayumi L Prins
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

5.  Seizure tests distinguish intermittent fasting from the ketogenic diet.

Authors:  Adam L Hartman; Xiangrong Zheng; Emily Bergbower; Michiko Kennedy; J Marie Hardwick
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

Review 6.  Purines and neuronal excitability: links to the ketogenic diet.

Authors:  S A Masino; M Kawamura; D N Ruskin; J D Geiger; D Boison
Journal:  Epilepsy Res       Date:  2011-08-30       Impact factor: 3.045

Review 7.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

8.  The ketogenic diet suppresses the cathepsin E expression induced by kainic acid in the rat brain.

Authors:  Hyun Jeong Jeong; Hojeong Kim; Yoon-Kyoung Kim; Sang-Kyu Park; Dong-Won Kang; Dojun Yoon
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 9.  Ketone bodies as a therapeutic for Alzheimer's disease.

Authors:  Samuel T Henderson
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

10.  The ketogenic diet has no effect on the expression of spike-and-wave discharges and nutrient transporters in genetic absence epilepsy rats from Strasbourg.

Authors:  Astrid Nehlig; Franck Dufour; Marianne Klinger; Lisa B Willing; Ian A Simpson; Susan J Vannucci
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.